medigraphic.com
Revista Médica Sinergia

2023, Número 02

<< Anterior Siguiente >>

Revista Médica Sinergia 2023; 8 (02)


Actualización sobre el síndrome de ovario poliquístico

Castro TGR, Rojas MKJ, Min KH

Idioma: Español
Referencias bibliográficas: 42
Paginas:
Archivo PDF: 193.83 Kb.


RESUMEN

El síndrome de ovario poliquístico (SOP) es la endocrinopatía más frecuente en mujeres en edad reproductiva. Tiene una etiología de probable origen multifactorial, mas no bien conocida actualmente. Las manifestaciones clínicas incluyen alteraciones menstruales y datos de hiperandrogenismo (hirsutismo, acné). Los criterios diagnósticos están definos en los Criterios de Rotterdan, en adolescentes difiere de los criterios utilizados en mujeres adultas, ya que algunas de las manifestaciones se dan de forma fisiológica por la inmadurez del eje hipotálamo-hipófisis-ovárico. Además, deben descartarse otros diagnósticos diferenciales. El manejo del SOP es multimodal y multidisciplinario, combinando cambios de estilo de vida y uso de fármacos.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Zoroddu MA, Aaseth J, Crisponi G, Medici S, Peana M, Nurchi VM. The essential metals for humans: a brief overview. Journal of Inorganic Biochemistry. 2019;195:120-9.

  2. Skogestad J, Aronsen JM. Hypokalemia-induced arrhythmias and heart failure: new insights and implications for therapy. Frontiers in physiology. 2018;9:1500.

  3. Fiaccadori E, Sabatino A, Barazzoni R, Carrero JJ, Cupisti A, De Waele E, et al. ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease. Clinical Nutrition. 2021;40(4):1644-68.

  4. Dhondup T, Qian Q. Acid-Base and Electrolyte Disorders in Patients with and without Chronic Kidney Disease: An Update. Kidney Dis (Basel). 2017;3(4):136-48.

  5. Krogager ML, Torp-Pedersen C, Mortensen RN, Køber L, Gislason G, Søgaard P, et al. Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data. European Heart Journal. 2017;38(2):104-12.

  6. Burrello J, Monticone S, Losano I, Cavaglia G, Buffolo F, Tetti M, et al. Prevalence ofhypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit. Hypertension. 2020;75(4):1025-33.

  7. Kardalas E, Paschou SA, Anagnostis P, Muscogiuri G, Siasos G, Vryonidou A. Hypokalemia: a clinical update. Endocr Connect. 2018;7(4):R135-r46.

  8. Palmer BF, Clegg DJ. Blood pressure lowering and potassium intake. Nature Publishing Group; 2020. p. 671-2.

  9. Calvo MS, Whiting SJ. School Meal Programs Require Higher Vitamin D Fortification Levels in Milk Products and Plant-based Alternatives: Evidence from the National Health and Nutrition Examination Surveys (NHANES 2001-18). Advances in Nutrition. 2022.

  10. Kumssa DB, Joy EJ, Broadley MR. Global Trends (1961–2017) in human dietary potassium supplies. Nutrients. 2021;13(4):1369.

  11. DeSalvo KB, Olson R, Casavale KO. Dietary Guidelines for Americans. Jama. 2016;315(5):457-8.

  12. Sussman EJ, Singh B, Clegg D, Palmer BF, Kalantar-Zadeh K. Let them eat healthy: can emerging potassium binders help overcome dietary potassium restrictions in chronic kidney disease? Journal of Renal Nutrition. 2020;30(6):475-83.

  13. Smith ZR, Horng M, Rech MA. Medication‐Induced Hyperlactatemia and Lactic Acidosis: A Systematic Review of the Literature. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2019;39(9):946-63.

  14. Sharif S, Tang J. Potassium Derangements: A Pathophysiological Review, Diagnostic Approach, and Clinical Management. 2022.

  15. Willson C. The clinical toxicology of caffeine: A review and case study. Toxicology reports. 2018;5:1140-52.

  16. Holm-Yildiz S, Krag T, Witting N, Duno M, Soerensen T, Vissing J. Vacuoles, often containing glycogen, are a consistent finding in hypokalemic periodic paralysis. Journal of Neuropathology & Experimental Neurology. 2020;79(10):1127-9.

  17. Hoorn EJ, Gritter M, Cuevas CA, Fenton RA. Regulation of the renal NaCl cotransporter and its role in potassium homeostasis. Physiological reviews. 2020;100(1):321-56.

  18. Clase CM, Carrero J-J, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, et al. Potassium homeostasis and management of dyskalemia inkidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2020;97(1):42-61.

  19. Long B, Warix JR, Koyfman A. Controversies in management of hyperkalemia. The Journal of Emergency Medicine. 2018;55(2):192-205.

  20. Ota R, Hirata A. Relationship between renal dysfunction and electrolyte abnormalities in hematopoietic stem cell transplant patients treated with foscarnet. Journal of Chemotherapy. 2021;33(8):539-46.

  21. Khan S, Khan SU. Adverse drug event of hypokalaemia‐induced cardiotoxicity secondary to the use of laxatives: A systematic review of case reports. Journal of Clinical Pharmacy and Therapeutics. 2020;45(5):927-36.

  22. Tran TT, Pease A, Wood AJ, Zajac JD, Mårtensson J, Bellomo R, et al. Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols. Front Endocrinol (Lausanne). 2017;8:106.

  23. Molin CZD, Trevisol DJ. Persistent severe hypokalemia: Gitelman syndrome and differential diagnosis. J Bras Nefrol. 2017;39(3):337-40.

  24. Kovesdy CP, Appel LJ, Grams ME, Gutekunst L, McCullough PA, Palmer BF, et al. Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension. J Am Soc Hypertens. 2017;11(12):783-800.

  25. Elsayes KM, Emad-Eldin S, Morani AC, Jensen CT. Practical Approach to Adrenal Imaging. Radiol Clin North Am. 2017;55(2):279-301.

  26. Skogestad J, Aronsen JM. Hypokalemia-Induced Arrhythmias and Heart Failure: New Insights and Implications for Therapy. Front Physiol. 2018;9:1500.

  27. Vanholder R, Van Biesen W, Nagler EV. Treating potassium disturbances: kill the killers but avoid overkill. Acta Clin Belg. 2019;74(4):215-28.

  28. Iacobelli S, Guignard JP. Renal aspects of metabolic acid-base disorders in neonates. Pediatr Nephrol. 2020;35(2):221-8.

  29. Shao D, Wang S, Zhou S, Cai Q, Zhang R, Li H, et al. Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias: A case report. Medicine (Baltimore). 2018;97(50):e13608.

  30. Clase CM, Carrero JJ, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, Kovesdy CP, Kline GA, Lindner G, Obrador GT, Palmer BF, CheungM, Wheeler DC, Winkelmayer WC, Pecoits-Filho R. Conference Participants. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020 Jan;97(1):42-61. DOI: 10.1016/j.kint.2019.09.018. Epub 2019 Oct 10. PMID: 31706619.

  31. Shaw N, Rosenfield R. Definition, clinical features, and differential diagnosis of polycystic ovary syndrome in adolescents. UpToDate [Internet]. 2022. Disponible en: https://www-uptodate-com.ezproxy.sibdi.ucr.ac.cr/contents/definition-clinical-features-and-differential-diagnosis-of-polycystic-ovary-syndrome-in-adolescents?search=Definition,%20clinical%20features,%20and%20differential%20diagnosis%20of%20polycystic%20ovary%20syndrome%20in%20adolescents&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

  32. Roldán M, Corredor A. Síndrome de ovario poliquístico en la adolescente. Pediatr Integral [Internet]. 2020:[258 – 67 pp.]. Disponible en: https://www.pediatriaintegral.es/publicacion-2020-07/sindrome-de-ovario-poliquistico-en-la-adolescente/

  33. Shaw N, Rosenfield RL. Diagnostic evaluation of polycystic ovary syndrome in adolescents. UpToDate. [Internet]. 2022. Disponible en: https://www-uptodate-com.ezproxy.sibdi.ucr.ac.cr/contents/diagnostic-evaluation-of-polycystic-ovary-syndrome-in-adolescents?search=diagnostic%20evaluation%20of%20polycystic%20ovary%20syndrome%20in%20adolescence%20&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

  34. Garad RMT, Helena J. Polycystic ovary syndrome: improving policies, awareness, and clinical care. Current Opinion in Endocrine and Metabolic Research [Internet]. 2020; 12:[112-8 pp.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S2451965020300417

  35. Freire AA, Andrea Gryngarten, Mirta Ropelato, María Gabriela. Síndrome de Ovario Poliquístico (SOP) en la adolescencia. Rev Hosp Niños [Internet]. 2018; 60. Disponible en: https://ri.conicet.gov.ar/handle/11336/91254

  36. Lizneva DS, L Walker, W Brakta, S Gavrilova-Jordan, L Azziz, R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril [Internet]. 2016; 106(1):[5-16 pp.].

  37. Abbott DH, Greinwald EP, Levine JE. Developmental origins of polycystic ovary syndrome: Everything starts in utero. Polycystic Ovary Syndrome [Internet]. 2022; 2

  38. Fitzgerald SS, Catherine Gooding, Holly C DiVasta, Amy D. Characteristics of Adolescents with Differing Polycystic Ovary Syndrome Phenotypes,. Journal of Pediatric and Adolescent Gynecology [Internet]. 2020; 33(6):[697-702 pp.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S1083318820303120

  39. Li JW, Qi Chiu Wang, Chi Wang, Rui H.Y. Ng, Ernest Liu, Jian-Ping Willem, Ben Mol, J Wu, Xiao-Ke Li, Wen-Tao. Endocrine characteristics, body mass index and metabolic syndrome in women with polycystic ovary syndrome. Reproductive BioMedicine Online [Internet]. 2019; 39(5):[868-76 pp.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S1472648319306017

  40. Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics. Metabolism. [Internet]. 2019; 92:[108-20 pp.]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0026049518302336

  41. Sari S, Aybüke Celik N, Cicek AU. Body Perception, Self-Esteem, and Comorbid Psychiatric Disorders in Adolescents Diagnosed with Polycystic Ovary Syndrome. J ournal of Pediatric and Adolescent Gynecology [Internet]. 2020; 33(6):[691-6 pp.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S1083318820303156

  42. Rothenberg SS, Beverley R, Barnard E, Baradaran-Shoraka M, Sanfilippo JS. Polycystic ovary syndrome in adolescents. Best Practice & Research Clinical Obstetrics & Gynaecology [Internet]. 2018; 48:[103-14 pp.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S1521693417301268




2020     |     www.medigraphic.com